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Translation initiation factor 5A (IF5A) is essential and highly conserved in Eukarya (eIF5A) and Archaea (aIF5A). The activity
of IF5A requires hypusine, a posttranslational modification synthesized in Eukarya from the polyamine precursor spermidine.
Intracellular polyamine analyses revealed that agmatine and cadaverine were the main polyamines produced in Haloferax volcanii
in minimal medium, raising the question of how hypusine is synthesized in this halophilic Archaea. Metabolic reconstruction led
to a tentative picture of polyamine metabolism and aIF5A modification in Hfx. volcanii that was experimentally tested. Analysis
of aIF5A from Hfx. volcanii by LC-MS/MS revealed it was exclusively deoxyhypusinylated. Genetic studies confirmed the role of
the predicted arginine decarboxylase gene (HVO 1958) in agmatine synthesis. The agmatinase-like gene (HVO 2299)was found to
be essential, consistent with a role in aIF5A modification predicted by physical clustering evidence. Recombinant deoxyhypusine
synthase (DHS) from S. cerevisiaewas shown to transfer 4-aminobutyl moiety from spermidine to aIF5A fromHfx. volcanii in vitro.
However, at least under conditions tested, this transfer was not observed with the Hfx. volcanii DHS. Furthermore, the growth of
Hfx. volcaniiwas not inhibited by the classical DHS inhibitor GC7.We propose a model of deoxyhypusine synthesis inHfx. volcanii
that differs from the canonical eukaryotic pathway, paving the way for further studies.
1. Introduction
The translation initiation factor 5A (IF5A) is highly con-
served in Eukaryotes (eIF5A) and Archaea (aIF5A), whereas
bacteria harbor the homolog elongation factor P (EF-P). IF5A
performs multiple intracellular functions and is involved in
cell growth and death [1, 2]. While both eIF5A and EF-P
proteins had been initially linked to translation initiation
[1, 3], recent studies have shown that they are required for
the efficient translation of proteins containing polyproline
stretches (Pro-Pro-Pro; Pro-Pro-Gly) [4–10].
Major differences between IF5A and EF-P exist, even if
their core function in translation is conserved. First, both
eIF5A and aIF5A are essential [11, 12] whereas deletion
of bacterial efp can be viable and leads to a range of
phenotypes depending on the organism [13–16]. Second, the
posttranslational modification of a strictly conserved lysine
(K50, Human eIF5A) into pN𝜀-(4-amino-2hydroxybutyl)-
lysine or hypusine is required for eIF5A activity and the
hypusine modification pathway is conserved in Eukaryotes
[11]. Conversely, hypusine is not found in the bacterial EF-
P proteins where the equivalent lysine can be modified by the
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addition of a 𝛽-lysine residue [17–21] or by rhamnosylation
[22, 23].
The eukaryotic hypusine synthesis pathway contains two
consecutive steps [11, 24–27]. The first enzyme, deoxyhy-
pusine synthase (DHS), catalyzes the transfer of the 4-
aminobutyl moiety of spermidine to the target lysine residue
forming the deoxyhypusine intermediate [26]. This inter-
mediate is then hydroxylated by deoxyhypusine hydroxylase
(DOHH) to form the biologically active hypusinylated factor
[11]. N1-Guanyl-1,7-diaminoheptane (GC7), a spermidine
homolog, very efficiently inhibits the first step of hypusina-
tion by binding to DHS [28, 29]. In Eukaryotes, the hypusine
modification of eIF5A occurs shortly after the synthesis of
eIF5A and no pool of unmodified proteins has ever been
detected [30, 31]. Interestingly, although the deoxyhypu-
sine/hypusine modification is essential in all eukaryotes,
only DHS is essential in Saccharomyces cerevisiae and eIF5A
partially modified with deoxyhypusine is functional [1, 3].
The archaeal aIF5A proteins and their modification path-
ways are poorly characterized. DHS homologs are present in
all sequenced archaeal genomes; however to date, no DOHH
orthologue has been identified in any archaeal genomes
or proteomes [25, 26], raising questions about the nature
of this final modification in Archaea. Early analyses based
on amino acid composition data reported the presence of
both hypusine and deoxyhypusine in Archaea [32]. Hypusine
was detected in several Crenarchaea like Sulfolobus acido-
caldarius, Pyrodictium occultum, Thermoproteus tenax, and
Acidianus ambivalens. However, high levels of deoxyhypu-
sine but no (or only low levels) traces of hypusine were
found in Euryarchaeota (i.e., halobacteriales, methanogen,
thermococcales, and thermoplasmales) [32] and the specific
nature of themodification found in aIF5A proteins was never
confirmed by mass-spectrometry (MS) methods. Growth
inhibition by GC7 has been reported in four archaeal species
S. acidocaldarius, Sulfolobus solfataricus,Halobacterium halo-
bium DSM 670, and Haloferax mediterranei DSM1411 [33],
suggesting that the archaeal deoxyhypusine pathway is essen-
tial, as in eukaryotes. S. acidocaldarius aIF5A is to date
the only archaeal protein for which the presence of the
hypusine modification has been experimentally confirmed
by amino acid composition [34]. The presence of the DHS
encoding genes in archaeal genomes, combinedwith the GC7
inhibition results, strongly suggests that deoxyhypusine is
synthesized by similar mechanisms in Archaea and Eukarya,
yet many questions remain.
Spermidine is the 4-aminobutyl donor for the eukaryotic
DHS enzyme [11] but the great diversity of polyamines found
in Archaea suggests this might not always be the case in
this kingdom of life. Indeed, spermidine was detected in
Thermococcus kodakarensis [35] and in various Sulfolobus
species [36] and homospermidine (that could also be an
aminobutyl donor forDHS [37]) was found to be an abundant
polyamine in methanogens [38] (Table S1). However, the
composition of intracellular polyamines was analyzed in 117
archaeal halophiles strains and trace amounts of spermidine
and/or spermine were detected in only 20 strains [39]. Agma-
tine appears to be the major accumulating polyamine in this
order (Table S1 in Supplementary Material available online
at http://dx.doi.org/10.1155/2016/7316725) [36, 40, 41]. Agma-
tine is the precursor of agmatidine, an essential modification
of the anticodonwobble cytosine in archaeal tRNAIleCAU [42–
44]. Agmatine is therefore an essential archaeal metabolite
that can be either synthesized de novo or salvaged [42]. More
generally, while archaeal polyaminemetabolic pathways have
been partially elucidated in thermophilicArchaea [35, 45], lit-
tle is known about polyamine pathway in halophilic Archaea.
By combining metabolic reconstruction, genetics, com-
parative genomics, and biochemical studies, we set out
to elucidate both the polyamine and aIF5A modification
pathways in the model halophile Haloferax volcanii.
2. Experimental Procedures
2.1. Strains and Growth Conditions. All strains, plasmids,
and oligonucleotides used in this study are listed in Tables
S2 and Table S3. Hfx. volcanii H26 was used as the parent
strain. Escherichia coli derivatives were routinely grown in
LB-Lennox (LB) (Fisher) or LB agar (Fisher) at 37∘C and sup-
plemented when required with ampicillin (Amp, 100 𝜇g/mL).
Hfx. volcanii strains were grown at 42∘C in either rich (ATCC
974) or minimal media (Hv min) as previously described
[46]. Novobiocin (0.1 𝜇g/mL) and agar (5 g/L) were included
as needed. Uracil was dissolved to 50mg/mL in 100% (v/v)
DMSO and added to growthmedium at a final concentration
of 50 𝜇g/mL. Transformations of E. coli andHfx. volcaniiwere
performed as previously described [46].
2.2. Plasmid and Strain Constructions
2.2.1. HVO 1958 and HVO 2299 Deletions. Plasmids used to
delete theHVO 1958 and HVO 2299 genes were constructed
as described previously [44]. Briefly, ∼600 bp regions up-
and downstream of HVO 1958 and HVO 2299 were PCR-
amplified from purified genomic DNA using Phusion poly-
merase (NEB) and the oligonucleotides listed in Table S3
and then inserted using In-Fusion (Clontech) into pTA131,
linearized by digestion with EcoRI and XhoI. The resulting
plasmids, pIKB313 and pIKB298, containing the deletion
constructs for HVO 1958 and HVO 2299, respectively, were
validated by sequencing before passaging through E. coli
Inv110 (Invitrogen). The plasmids were subsequently trans-
formed into Hfx. volcanii strain H26, and the deletion
strains were generated by the pyrE2-based “pop-in/pop-out”
deletion method [47, 48], with standard media preparations
[46] except that the media was supplemented with 100𝜇M
agmatine for deletion of HVO 1958 or with or without
1mM putrescine for the deletion of HVO 2299. Deletion of
HVO 1958 was validated by PCR methods using the primers
ext f and ext r (Table S3), generating strain VDC3253 (Table
S2).
2.3. LSP5061. H26 was transformed with pIKB298 and the
pop-in was generated [47, 48] with standard media prepa-
ration. Ten isolated colonies of the pop-in were pooled
together and grown in liquid to generate competent cells [47].
The competent “pop-in strain” was transformed with the
Archaea 3
pLSP21 plasmid that was constructed by cloning HVO 2299
under the control of the PTNA promoter into the pJAM202
derivative pPT002 (Table S2) in the presence of 2.5mM
tryptophan andnovobiocin (0.1𝜇g/mL) before generating the
pop-out (LSP5061) in presence of 2.5mM tryptophan and
novobiocin (0.1𝜇g/mL) [49]. Deletion ofHVO 2299 from the
Hfx. volcanii genome was validated by PCR methods using
the primers FW-391 and RV-391 (Table S3).
2.3.1. TIF5A-C-Term His Integrant. VDC2577, containing the
native copy of aIF5A (HVO 2300) with a C-terminal His-tag
(6x His), was generated by transformation of Hfx. volcanii
H26 with pIKB473 (Table S2), constructed as described in
previously [44], with the oligonucleotides listed in Table S3.
2.4. Physiology Studies
2.4.1. Stress Conditions. Cells were subjected to different
stress conditions as described in [50]. Briefly, H26 were
inoculated into 5mL ATCC 974 and then diluted into 25mL
of fresh ATCC 974 at OD
600
of 0.0074. The cells were grown
at 42∘C for 24 hours in order to reach early exponential
growth phase (OD
600
= 1.29 ± 0.049) before the stress was
applied for 4 hours (oxidative and cold shock) or 24 hours
(proteasome inhibitor). Oxidative stress was induced by the
addition of H
2
O
2
to a final concentration of 0.78% (w/v) for
4 hours at 42∘C with shaking (200 rpm). For cold shock, the
cells were grown at 30∘C for 4 hours with shaking (200 rpm).
The proteasome inhibitor, bortezomib (LCLaboratories), was
added at 100 𝜇M final concentration as described in [51].
Cultures were incubated with shaking (200 rpm) at 42∘C for
24 hours. After the stress, growth was monitored and 2mL
of culture at an OD
600
0.043 was harvested for immunoblot
analysis.
2.4.2. Culture in Presence of GC7. To monitor the effect of
N1-guanyl-1,7-diaminoheptane (GC7) (Santa Cruz Biotech-
nologies) on Hfx. volcanii growth, H26 was inoculated into
5mL of ATCC 974 medium and grown to log phase. Cells
were subcultured into 5mL of fresh Hv min medium until
exponential phase. The cells (1mL at an OD
600
= 1) were
washed 4 times in Hv min medium and serial dilutions in
Hv min medium were spot-plated (15𝜇L) onto solid Hv min
agar in the absence or presence of 1mM GC7. The cells were
grown at 45∘C for 4 days. The experiments were done with
two biological replicates (i.e., two independent cultures) and
three technical duplicates (three measurements per culture).
2.4.3. Culture in Presence of Agmatine. Hfx. volcanii H26
(WT, parent) and Δ𝑎𝑑𝑐 (VDC3253) were grown in 5mL
ATCC 974 medium supplemented with mM agmatine at
42∘C. Cells were then subcultured into 5mLHv minmedium
at 42∘C. Cells grown to stationary phase (after 48 hours at
42∘C) were washed 4 times in Hv min medium. Cell density
was normalized by dilution to OD
600
of 1 and serial dilutions
were spot-plated (15 𝜇L) on solid agar Hv min medium in
the absence or presence of agmatine (1 𝜇M or 5𝜇M). Each
experiment was performed with two biological replicates and
three technical replicates.
2.5. Polyamines Analyses
2.5.1. Sample Preparation. H26 was grown in 1 L of Hv min
medium in 2.8 L Fernbach flasks at 42∘C (200 rpm). At
different points of growth (early exponential OD
600
= 0.0805,
mid-exponential OD
600
= 0.86, and late exponential OD
600
= 1.2), cells were harvested at 5,500 rpm (SLA 3000, Sorvall)
for 40min at 4∘C and then washed with 50mM HEPES,
2MNaCl, and pH 8 buffer. The pellets were frozen in liquid
nitrogen prior to desiccation. Experiments were done with
two biological replicates.
2.5.2. Polyamines Extraction. An appropriate amount of the
cells (between 7 and 110mg) was transferred into an Eppen-
dorf tube and suspended in 1mL of 10% trichloroacetic acid
solution.The suspension was shaken for 1min repeatedly and
kept at room temperature overnight.The suspensionwas then
centrifuged and the supernatant was filtered using 0.2 𝜇m
membrane filter in order to remove fine dust. The filtrate
was diluted in water if necessary and applied on a polyamine
analyzer.
2.5.3. Polyamines Analysis. Polyamines were analyzed with a
CK10S column (8.0 × 70mm, Mitsubishi Kasei) as described
previously [52]. Briefly, the column was developed with Type
2 buffer (citrate buffer containing 125 g/L of KCl) at 60∘C,
at a flow rate of 2mL/min. Polyamines were detected using
o-phthalaldehyde and fluorescence at 𝜆450 nm (excitation at
𝜆340 nm) was recorded. The recorded chart was analyzed as
described previously [52]. For each biological sample, two
technical replicates were analyzed. The standard used was a
mixture of 2.0 𝜇M agmatine and 2.8 𝜇M cadaverine.
2.6. Protein Purification
2.6.1. aIF5A-His-C-Term Purification. E. coli Rosetta gami 2
(DE3) (Novagen) strains freshly transformed with plasmid
pLSP24 were grown in 1 L LB Amp in 2.8 L Fernbach
flasks at 37∘C (200 rpm) in the presence of 2% glucose.
Isopropyl 𝛽-D-1-thiogalactopyranoside (IPTG) was added
to a final concentration of 0.4mM at log phase (OD
600
of 0.4–0.6 units), and cultures were shifted to 25∘C for 3
hours (200 rpm) prior to harvest. Cells were harvested by
centrifugation (5,000×g, 4∘C, 15min) and stored at −80∘C.
Cells (10-gram wet weight) were resuspended in 20–25mL of
20mM Tris-HCl pH 8 and 2MNaCl (buffer A) and broken
by passage three times by French Press at a pressure of
2000 psi. After 15min of centrifugation at 3,000×g (4∘C) to
remove unbroken cells, the supernatant was filtered through
a 0.8 𝜇Mcellulose acetatemembrane (Fisher Scientific, USA).
The supernatant was then applied to a HisTrap HP column
(1mL, GE Healthcare) preequilibrated with buffer A with
40mM imidazole and washed with the same buffer at room
temperature. aIF5A-C-term His-tag protein was eluted from
the column with 20mM Tris-HCl pH 8, 2MNaCl, and
500mM imidazole (buffer B). Purified proteins were detected
by Western blotting and/or Coomassie Blue R-250 staining
after separation by 10% SDS-PAGE. The purified proteins
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were precipitated by trichloroacetic acid (TCA) as described
by Sanchez [53] before loading on SDS-PAGE.
2.6.2. T7-His-DHS. Hfx. volcanii LSP5021 (H26 carrying
pLSP23) was used for the purification of T7-His-DHS.
LSP5021 (40-gramwet weight) were resuspended in 80mL of
buffer A and broken by passage three times through a French
Press at a pressure of 2000 psi as described before. Briefly, the
supernatant was applied to a HisTrap HP column (5mL, GE
Healthcare).Then the fractionwas dialyzed overnight against
1 L of buffer A. The sample was applied to a hydroxyapatite
column (HTP) (25mL) preequilibrated with buffer A at flow
rate of 1mL/min and eluted with a continuous gradient of
Tris-HCl 20mM, 2M NaCl, and 400mM sodium phosphate
pH 8. Fractions of 1mL were collected. The T7-His-DHS was
eluted from the column with 40mM of sodium phosphate
in buffer A. The eluate was concentrated (Vivaspin 3,000
Dalton molecular weight cut off, Sartorius Stedim Biotech)
and applied to a Sephacryl S-200 HR gel filtration column
equilibrated with buffer A at a flow rate of 0.3mL/min.
Fractions of 1mL were collected.
2.6.3. Purification of IF5A and DHS from Saccharomyces cere-
visiae andThermococcus kodakarensis. Thecoding sequences
of the respective proteins were cloned into pET28a (+) vector
with an additional (6x) His-tag and TEV cleavage site using
oligo pairs depicted in the supplemental data (Table S3).
Proteins were overexpressed in BL21 E. coli cells grown at
37∘C from overnight culture in LB in presence of 50 𝜇g/mL
kanamycin. Protein expression was induced at OD
600
of 0.4
with a final concentration of 1mM IPTG (Roth). After 1
hour of expression cells were lysed using a microfluidizer
(Microfluidizer Processor Microfluidics Newton, USA). The
cell lysate was cleared using a SS34 rotor (Sorvall) at 4∘C and
44,100×g for 30min. Purification of His-tagged proteins was
done with Protino Ni-NTA agarose beads (Macherey-Nagel).
The final eluate was applied onto a Superdex HiLoad S75
16/60 column (GEHealthcare) to yield the final concentrated
protein in gel filtration buffer (50mMHEPES pH 7.4, 50mM
KCl, 100mM NaCl, and 5mM 2-mercaptoethanol).
2.7. Deoxyhypusine Synthase Assay
2.7.1. Thermococcus kodakarensis. DHS modification assay
was performed in presence of either 75𝜇M radioactive
[14C] spermidine trihydrochloride (GE Healthcare) or 3 𝜇M
putrescine dihydrochloride [1,4-3H(N)] (Perkin Elmer). The
reaction mixture contained the substrates 5 𝜇M of S. cere-
visiae eIF5A or T. kodakarensis aIF5A, as well as 2mM
nicotinamide adenine dinucleotide (NAD+), 2.5 𝜇M S. cere-
visiae DHS, or T. kodakarensis DHS in 0.2M glycine-NaOH
buffer, pH 9.4 (total volume 30 𝜇L). After 120 minutes of
incubation at 37∘C, incorporation of radiolabeled deoxyhy-
pusine wasmonitored using a 16.5% Tricine-PAGE gel, which
was subsequently dried and exposed to high-performance
autoradiography films (GE Healthcare). Color Prestained
Broad Range Protein Standard (NEB) was used as molecular
weight marker.
2.7.2. Haloferax volcanii. DHS was tested in cell extract
overexpressing DHS. For DHS assay, the experiment was
conducted in presence of either 75 𝜇Mradioactive [14C] sper-
midine trihydrochloride (111mCi/mmol, GE Healthcare) or
3 𝜇M putrescine dihydrochloride [1,4-3H(N)] (62Ci/mmol,
Perkin Elmer). Each 30 𝜇L sample contained 20𝜇L of Hfx.
volcanii extract (overexpressing DHS at a concentration of
3mg/mL), 5 𝜇L of 1.5mg/mL Hfx. volcanii aIF5A, 1 𝜇L of
100mM nicotinamide adenine dinucleotide (NAD+), and
the respective substrate. All samples were incubated at 42∘C
for 2 hours. Due to the presence of high salt concentra-
tions in the Hfx. volcanii extract all samples were subjected
to buffer exchange (50mM HEPES, 100mMK(OAc) and
25mMMg(OAc)) via Amicon Ultra 0.5mL Ultracel 3 K
(Merck Millipore) before gel electrophoresis. The final sam-
ples were separated on a 16.5% Tricine gel. For evaluation of
the protein size Spectra Multicolor Low Range Protein Lad-
der (Thermo Scientific) was used. Dried gels were exposed
to high-performance autoradiography films (GE Healthcare)
to evaluate the occurrence of aIF5A modification by DHS in
the respective sample. The control samples with S. cerevisiae
DHS were prepared as described for the T. kodakarensis
DHS assay. To test the activity of Hfx. volcanii T7-His-DHS,
200 pmol of radioactive polyamines (agmatine, putrescine, or
spermidine) was mixed with 20 pmol of T7-His-DHS in the
presence or absence of 100 pmol of Hfx. volcanii aIF5A in
0.3M glycine-NaOH pH 9.0, 2MNaCl, and 1mM NAD for
1 hour at 40∘C.
2.7.3. Synthesis of Radiolabeled Agmatine. Since radiolabeled
agmatine is not available commercially, it was synthetized
from [14C] arginine (Perkin Elmer) using arginine decar-
boxylase (SpeA). The plasmid pAS1 (carrying speA-C-term-
His) was transformed into BL21 E. coli strain (Novagen)
and expressed in LB media. Cultures (200mL) were induced
with 1mM IPTG at OD
600
= 0.6 and grown for another 3
hours at 30∘C. Thirty minutes prior to induction, chaperons
were induced by addition of 1% (final concentration) of
ethanol into LB media. Protein was purified using Ni-
NTA spin columns (Qiagen) according to the manufacturer
protocol, followed by buffer exchange (into 50mM HEPES
pH7.4, 10mMMgCl
2
, 100mMNaCl, 50mMKCl, 5mMbeta-
mercaptoethanol, and 2% glycerol) using PD10 desalting
columns (GE Healthcare). Agmatine synthesis from [14C]
arginine (124 dpm/pmol) by SpeA was carried out in 0.3M
glycine-NaOH pH 9.0, 10mMMgCl
2
, and 1mM PLP at 37∘C
for 1 hour. The progress of the reaction was monitored using
Silica Plates (Merck Millipore) developed in butanol/acetic
acid/pyridine/formaldehyde 3 : 3 : 2 : 1 and exposed to high-
performance autoradiography films (GE Healthcare).
2.8. Analytical Procedures
2.8.1. Protein Concentration. Protein concentrations were
determined by the bicinchoninic acid method [54] (Thermo
Scientific Pierce BCA Protein Assay Kit, Rockford, IL)
with bovine serum albumin (BioRad) as the protein
standard.
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2.8.2. Electrophoresis. Protein samples were mixed in equal
volume ratio with 2x loading buffer (containing 125mM
Tris-HCL pH 6.8, 20mM 𝛽-mercaptoethanol, 4% (w/v) SDS,
20% (v/v) glycerol, and 0.01% (w/v) bromophenol blue) and
boiled for 15min. Samples were separated by 12% SDS-PAGE
or gradient gel 4–15% (Biorad), using a mini-Protean III cell
electrophoresis apparatus (Biorad) at 20mA constant current
at room temperature in a running buffer of 25mM Tris
and 190mM glycine at pH 8.3 with 0.1% (w/v) SDS. After
migration, proteins were stained in-gel with Coomassie Blue
R-250 or were detected by Western blotting.
2.8.3.Western Blotting. For aIF5A analysis during the growth
in ATCC at 42∘C, H26 cells (2mL at OD 0.043 of the culture)
were harvested via centrifugation (14,000×g, 10min, 25∘C)
and treated as described before. Proteins were separated
by SDS-PAGE (gradient gel 4–15%, Biorad) and transferred
onto PVDF membrane (GE Healthcare). Equivalent protein
loading was based on OD
600
of cell culture (0.086 units per
lane) and confirmed by staining parallel gels with Coomassie
Blue. aIF5A protein was detected via immunoblot using
TIF5A2 (1/10,000) or TIF5A3 (1/5,000), followed by a sec-
ondary anti-rabbit IgG antibody [HRP] (1/5,000) (GenScript,
USA). The rabbit polyclonal antibodies TIF5A2 and TIF5A3
were produced using, respectively, the synthetic peptides
CEIEYLEYEGQRKIV and MAKEQKQVRELQEGC (Gen-
Script, USA). Membranes were visualized via chemilumi-
nescence using Clarity western ECL (Biorad) with X-ray
film (Fisher). aIF5A C-term His was detected with the
anti C-term-His-HRP (Invitrogen) at a dilution 1/5,000. The
deoxyhypusine/hypusine modification was detected with the
antibody IU-88 (1/1,500) as described by [55].
2.9. Mass Spectrometry. Briefly, aIF5A was in-gel digested
with LysC (Wako) according to the protocol of Shevchenko
et al. [56] and desalted on C18-StageTips [57]. Peptides were
then separated by reversed-phase liquid chromatography
(LC) on a Dionex UltiMate RSLCnano 3000 system (Thermo
Fisher Scientific). LC conditions were as follows: 30min
3–40% B gradient (A: 0.1% formic acid, B: 0.1% formic
acid/80% acetonitrile) at a flow rate of 200 nL/min, using
75 𝜇m × 300mm fused silica emitter (New Objective, USA)
packed in-house with Reprosil-Pur C18-AQ 3𝜇m particles
(Dr.Maisch,Germany). Eluted peptideswere sprayed directly
into a Q Exactive mass-spectrometer (Thermo Fisher Sci-
entific) operated in data-dependent mode with up to ten
MS/MS scans (NCE = 25) being recorded for each precursor
ion scan. Peak lists for database search were prepared by
using MSConvert. Database search was performed with the
Mascot 2.3 search engine (Matrix Science) against the protein
sequence database containing aIF5A sequence and common
contaminant proteins, such as trypsin and keratins. Search
parameters were 5 ppm for precursor mass tolerance, 0.02Da
for Orbitrap MS/MS mass tolerance, and up to three missed
cleavages plus a number of variable modifications such as
oxidation (M), hypusinylation (K), and deoxyhypusinylation
(K). Peptide hits returned byMascot weremanually validated
and annotated using xiSPEC (http://spectrumviewer.org/).
2.10. Bioinformatics. The gene sequences were obtained
from NCBI. The BLAST tools [58] and resources at NCBI
(https://www.ncbi.nlm.nih.gov/) were used routinely. Multi-
ple sequence alignments were built using Clustal Omega [59]
or MultAlin [60]. Protein domain analysis was performed
using the Pfam database tools [61]. Transmembrane helices
were predicted with the TMHMM Server v. 2.0 (http://www
.cbs.dtu.dk/services/TMHMM-2.0/) [62]. Analysis of phylo-
genetic distribution and physical clustering was performed
with STRING (http://string-db.org/.) [63] and the SEED
Database [64].
3. Results and Discussion
3.1. Metabolic Reconstruction of Polyamines Metabolism and
aIF5AModification in Hfx. volcanii. Spermidine is the donor
for the eukaryotic DHS enzyme [11]. In a recent review on
polyamine metabolism in all kingdoms of life [37], a core
starter pathway for polyamine synthesis in Archaea through
the decarboxylation of arginine by arginine decarboxylase
(ADC) was proposed. Metabolic reconstruction in Hfx.
volcanii indicates that most of the core biosynthetic pathway
for the synthesis of spermidine is present (Figure 1(a)). Two
forms of ADC are found in Archaea [37]. The first type
is a pyruvoyl-dependent enzyme, and the corresponding
gene (TK0149) is essential for growth of T. kodakarensis
[65]. The second is a paralog of AdoMet decarboxylase
(AdoMet DC) that can decarboxylate arginine, found mainly
in Crenarchaeota [37]. Like T. kodakarensis, Hfx. volcanii
harbors a homolog of the pyruvoyl-dependent type encoded
by HVO 1958 (Figure 1(a)) [66].
The next step in the proposed archaeal spermidine
pathway is the formation of putrescine by hydrolysis by
the agmatinase/agmatine ureohydrolase (AUH) enzyme.The
AUH enzymes from Pyrococcus horikoshii and Methanocal-
dococcus jannaschii have been biochemically characterized
[67, 68], but no archaeal mutant was ever constructed. An
agmatinase family member, HVO 2299, is found in Hfx.
volcanii and could possibly catalyze this reaction (Figure 1(a))
[66].
Finally, spermidine synthase transfers the 3-aminopropyl
moiety fromdecarboxylatedadenosylmethionine(dcAdoMet)
to putrescine. Two members of the spermidine synthase
family are found inHfx. volcanii:HVO 0255 andHVO B0357
(Figure 1(a)) [66]. Deletion of the HVO B0357 gene did
not give rise to any phenotypes under the conditions tested
[44]. Interestingly, the N-terminal regions of HVO 0255 and
HVO B0357 and of halophilic homologs contain seven trans-
membrane domains (N-terminal transporter like domain)
(Fig. S1A). The presence of the N-terminal transporter like
domain in both of these proteins and the fact that the
putrescine binding residues are not conserved in theses
halophilic SpeE homologs (Fig. S1B) suggest that these
proteins might have other as yet undetermined roles.
Whereas AdoMet DC is present in T. kodakarensis [69],
no homologs of AdoMet DC were found in either Hfx.
volcanii ormore generally any sequenced halophiles (data not
shown). This raises the question of the potential source of
dcAdoMet in a putative spermidine synthase reaction.
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Figure 1: Proposed models of polyamines metabolism and aIF5A in Hfx. volcanii. (a) Predicted pathways of polyamines synthesis from
arginine substrate. Dashed arrows indicate proposed reaction; solid arrow indicates known reaction. (b–d) Proposed substrates of DHS.
HVO 1958 encodes a potential arginine decarboxylase; HVO 2299 an agmatinase-like; HVO 0255 a spermidine synthase; HVO B0182 a
spermidine synthase or a homospermidine synthase; and HVO 2297 a potential deoxyhypusine synthase.
Other genes putatively related to polyamine metabolism
in Hfx. volcanii include the HVO 0339 gene encoding
the essential agmatidine synthase TiaS (Figure 1(a)) [44]
and the HVO B0045 and HVO B0046 genes predicted
to encode L-2,4-diaminobutyrate decarboxylase and L-2,4-
aminobutyrate aminotransferase. It has been proposed that
these two enzymes participate in the synthesis of a 1,3-
diaminopropane-based siderophore such as rhizobactin 1021
or schizokinen [70].
Two members of the DHS family are found in Hfx.
volcanii HVO 2297 and HVO B0182 [66]. The HVO 2297
gene is physically clustered with the gene encoding aIF5a
(HVO 2300) (Figure 2). To our knowledge, the activity
of HVO 2300 (as aIF5A) has never been experimentally
validated, the gene is essential [12]. Hence, HVO 2297 is
a potential candidate for the canonical DHS enzyme and
HVO B0182 could be involved in homospermidine synthesis
as proposed by [37] (Figure 1(a)).
As summarized in Figure 1, metabolic reconstruction
gives only a tentative picture of polyamine metabolism
(Figure 1(a)) and the aIF5A modification pathway (Figures
1(b), 1(c), and 1(d)) in Hfx. volcanii. DHS could transfer the
aminobutyl group from spermidine to aIF5A (Figure 1(b))
but it is not clear if the spermidine pathway is present in
this organism since no AdoMet DC gene could be identified
(Figure 1(a)). Other possibilities already partially discussed
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Figure 2: HVO 2299 of Hfx. volcanii clusters with aIF5A. Physical gene clustering links genes encoding agmatinase, DHS, and aIF5A in
Euryarchaeota. In pink, aIF5A (HVO 2300 in Hfx. volcanii); in blue, agmatinase (HVO 2299 in Hfx. volcanii); in yellow, gene encoding
HVO 2298; DHS (HVO 2297 in Hfx. volcanii). Arrows represent the genes. Physical clustering was analyzed on the STRING database.
by [37] are that the Hfx. volcanii DHS (i) transfers directly
putrescine (Figure 1(b)) or the aminobutyl group of agmatine
to aIF5A (Figure 1(c)) and (ii) transfers agmatine to aIF5A,
with the agmatinase acting on the modified protein substrate
to produce the deoxyhypusinylated derivative (Figure 1(d)).
3.2. Hfx. volcanii aIF5A Is Expressed Throughout the Growth
Curve and Deoxyhypusinylated In Vivo. The Hfx. volcanii
gene predicted to encode aIF5a (HVO 2300) is essential [12],
but little else is known about this gene/protein in this organ-
ism. To obtain a better understanding of aIF5A in Archaea
and specifically in halophiles, aIF5A levels at different growth
phases were monitored by Western blot using Hfx. volcanii
anti-aIF5A antibodies (TIF5A2 and TIF5A3) (Figures 3(a)
and 3(b)). Both antibodies independently detected aIF5A at
around 20 kDa for an expected theoretical mass of 14.2 kDa.
The observed size difference is most likely due to the known
slow mobility of halophilic proteins on SDS-PAGE [71–73].
Similar levels of the aIF5A protein were detected for up to 25
hours of growth, after which the levels of aIF5A diminished
(Figure 3(b)). Few studies have the regulation of eIF5A in
Eukaryotes but it has been suggested that eIF5A levels are
regulated in a proteasome-dependent manner [74, 75]. The
effects of different stresses (proteasome inhibitor, cold shock,
and oxidative stress) on the level of aIF5A were therefore
monitored (as described in Section 2). We did not notice any
effect of the proteasome inhibitor (Fig. S2A) or cold shock
on the level of aIF5A (data not shown). Interestingly, the
presence of 0.78% (w/v) H
2
O
2
led to a change in the cell
lysate protein pattern (Figure 3(c)). For the same quantities
of cells (measured by OD), an additional higher molecular
weight band (around 85 kDa) was observed (Figure 3(c)).The
band at 85 kDa could be the result of protein modifications
or aggregation due to the stress. Additional work is needed to
understand the mechanisms that regulate aIF5A in Archaea
and more generally the effects of oxidative stress on the Hfx.
volcanii proteome.
In order to determine whether the Hfx. volcanii aIF5A
is modified by hypusine or deoxyhypusine, the protein
was purified to an apparent homogeneity as an 18 kDa
protein (Fig. S2B) from strain VDC2577 (TIF5A-C-term
His integrant) via affinity chromatography. We were able
to detect the deoxyhypusine/hypusine modification of the
purified aIF5A using the IU-88 antibody [55] (kind gift of
Dr. Mirmira) (Fig. S2B). The IU-88 antibody failed to detect
the modified aIF5A on cell lysates throughout the different
growth phases (data not shown). As this antibody recognizes
both the deoxyhypusine and hypusine forms of eIF5A [55],
the 18 kDa protein band was cut out from the SDS-PAGE,
digested with LysC, and analyzed by mass spectrometry (Fig-
ure 3(d)). This analysis confirmed that the purified protein is
aIF5A-modified with deoxyhypusine at the conserved lysine
(position 36) (Figure 3(d)). Furthermore, when comparing
the intensities for unmodified, hypusinylated, and deoxyhy-
pusinylated PGKHGSAK peptides, approximately 99% of the
aIF5A protein is deoxyhypusinylated. Our results confirm the
previous observation by amino acid analysis of the presence
of deoxyhypusine in halophiles [32] and show for the first
time by MS that Hfx. volcanii aIF5A is deoxyhypusinylated.
Our data suggest that Hfx. volcanii aIF5A is exclusively
deoxyhypusinylated in the cell, as no pool of unmodified
aIF5A was detected in the purified fraction and correlates
with the absence of DOOH homologs in this organism.
Indeed, in Eukaryotes hypusination of eIF5A appears to
be constitutive as hypusination occurs shortly after protein
synthesis with no evidence of modification turn-over [30, 31,
76, 77]. We propose that the deoxyhypusinylated aIF5A is
the active form in Hfx. volcanii, as it has been shown in S.
cerevisiae that the partially modified deoxyhypusine eIF5A
was functional [1, 3].
3.3. Intracellular Polyamines Composition of Hfx. volcanii.
Previous polyamine composition analysis studies of
halophilic Archaea were performed in various media types
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Figure 3: aIF5A produced inHfx. volcanii is deoxyhypusinylated and sensitive to oxidative stress. (a)Hfx. volcaniiH26 was grown at 42∘C in
ATCC974 (shaking at 200 rpm). 2mL of samples at OD
600
= 0.043 was harvested along the growth curve. (b) H26 cells pellets (2mL at OD
600
= 0.043 of the culture) were resuspended in SDS-PAGE loading buffer and boiled for 15min. Equivalent protein loading was based on OD
600
of cell culture (0.086 OD
600
units per lane), as demonstrated by staining with Coomassie Brilliant Blue R-250 (CB stain, with representative
55 kDa protein band of Hfx. volcanii presented). Proteins were separated via 4–15% reducing SDS-PAGE. aIF5A was detected by 𝛼-aIF5A
(anti-TIF5A2) immunoblot (IB). The experiments were performed with three biological replicates and the detection by anti-TIF5A2 or anti-
TIF5A3. The molecular mass indicated is in kDa. (c) Effect of oxidative stress on aIF5A level. The cells were grown for 24 hours and then
treated or not treated with 0.78% H
2
O
2
. Equivalent protein loading was based on OD
600
of cell culture (0.086 OD
600
units per lane). Lane
1, cells collected at 24 hours; lane 2, cells collected at +4 hours after no stress (control experiment); lane 3, cells collected at +4 hours after
0.78% H
2
O
2
treatment. Proteins were separated by 4–15% reducing SDS-PAGE. aIF5A was detected via 𝛼-aIF5A (anti-TIF5A2) immunoblot
(IB). The molecular mass indicated is in kDa. (d) Identification of the deoxyhypusine modification by LC-MS/MS analysis. The purified
aIF5A His-C-term was loaded on a SDS-PAGE 12%. The proteins were detected by staining with Coomassie Blue (Fig S2B), and the protein
band was cut and analyzed by LC-MS/MS analysis. Fragmentation spectrum for deoxyhypusinylated peptide PGKHGSAK is shown; xiSPEC
(http://spectrumviewer.org/) was used for annotation.
depending on the study and specific organism investigated,
making it difficult to compare results. Indeed, when cells
were grown in rich medium contamination with salvaged
polyamines can occur [40] as summarized in Table S1.
To obtain more information, the intracellular polyamine
composition in Hfx. volcanii H26 was analyzed by HPLC.
Intracellular polyamines were extracted at different growth
stages (20 hours, 35 hours, and 40 hours) of cells grown in
minimal medium (Hv min). Two major peaks were detected
at the position of agmatine and cadaverine (Figure 4). In
these conditions, no changes in polyamines composition
during growth were observed (Figure 4 and Fig. S3).
Agmatine was found to be the more abundant polyamine
at all growth stages (Figure 4(b) and Fig. S3). This result
confirms previous studies assigning agmatine as the major
polyamine in halophilic archaea and in Hfx. volcanii (Table
S1) [41, 78–80]. Hamana et al. reported the presence of a
small amount of putrescine when Hfx. volcanii was grown in
rich medium [41] (Table S1) (medium NCIMB 2012 at 30∘C).
This result was not reproduced in minimal medium. The
presence of cadaverine was not predicted from the initial
metabolic reconstruction (Figure 1(a)). It has been shown in
some Bacteria that the L-2,4-diaminobutyrate decarboxylase,
involved in siderophore synthesis, can also function as a
lysine decarboxylase [70]. Our results suggest that this could
also be the case in Hfx. volcanii as the gene HVO B0045 is
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Figure 4: Intracellular polyamines analyses in Hfx. volcanii
H26. H26 was grown at 42∘C in Hv min medium. Intracellular
polyamines from Hfx. volcanii H26 were extracted after 20 hours
of growth. (a), peak standards; (b), samples after 20 hours of
growth. Thirty-seven mg of extracts was injected. The ratio agma-
tine/cadaverine is 6.96±3.28.The injection is indicated by the arrow;
∗unexpected noise derived from buffer.
predicted to encode L-2,4-diaminobutyrate decarboxylase.
Cadaverine had previously been reported in a few halophilic
Archaea (Table S1) and it might have a role in resistance
of these organisms to high salt since this metabolite has
been linked to pH and salt resistance [81, 82]. The absence
of spermidine is also consistent with previous work (Table
S1) and with the fact that no dcSAM synthesis enzyme is
encoded by Hfx. volcanii (Figure 1(a)). These results raise the
question of the role of the SpeE homologs (HVO 0255 and
HVO B0357) in this halophile.
3.4. Arginine Decarboxylase Is Essential for the Growth of
Hfx. volcanii. To confirm thatHVO 1958 encodes an arginine
decarboxylase, the gene was deleted (Fig. S4A-B) and the
growth of the deletion strain was compared to its parent
(H26) at 42∘C in the absence (Figure 5(a)) or presence of
agmatine (Figures 5(b) and 5(c)). The ΔHVO 1958 strain is
H26
100 10−1 10−2 10−3 10−4 10−5
Δadc
0 𝜇M agmatine
(a)
H26
100 10−1 10−2 10−3 10−4 10−5
Δadc
1 𝜇M agmatine
(b)
100 10−1 10−2 10−3 10−4 10−5
H26
Δadc
5 𝜇M agmatine
(c)
Figure 5: Agmatine is essential for the growth of the Hfx. volcanii
Δ𝑎𝑑𝑐 strain. Hfx. volcanii H26 (WT, parent) and Δ𝑎𝑑𝑐 (HVO 1958)
were diluted to an OD
600
of 1 and then spot-plated (15 𝜇L) on solid
agar Hv min medium in serial dilutions as indicated: (a) in absence
of agmatine; (b) in presence of 1 𝜇M agmatine; (c) in presence of
5 𝜇Magmatine. Each experimentwas performedwith two biological
replicates and three technical replicates (for description of biological
versus technical replicates).
auxotrophic for agmatine and requires 5 𝜇Magmatine for full
growth (Figure 5(c)) andwas therefore renamedΔ𝑎𝑑𝑐. Partial
growth was observed at lower agmatine concentrations (Fig-
ure 5(b)) but no growth was observed for <1 𝜇M agmatine
(data not shown). As already seen with the T. kodakarensis
Δ𝑎𝑑𝑐 strain [65], growth of the Hfx. volcanii Δ𝑎𝑑𝑐 mutant
could only be rescued by agmatine and not by any of the
other tested polyamines such as putrescine, spermidine,
cadaverine, or ornithine (Fig. S5). Moreover, the addition
of polyamines in the media had no effect on the growth of
the parent strain Hfx. volcanii H26 (Fig. S5). These genetic
experiments support the model in which the HVO 1958
encoded ADC is the first enzyme of polyamine synthesis in
Hfx. volcanii producing the essential intermediate agmatine
(Figure 1(a)). Our genetic studies corroborate our polyamines
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analyses since deleting the predicted arginine decarboxylase
gene (HVO 1958) led to an agmatine auxotroph strain. The
agmatine produced by Hfx. volcanii ADC is certainly a
precursor to the formation of the essential agmatidine tRNA
modification catalyzed by TiaS (Figure 1(a)), but it could also
be required for the formation of the essential deoxyhypusine
modification as a direct substrate of DHS (Figures 1(c) and
1(d)) or as the precursor of the final polyamine substrate for
the DHS reaction (Figures 1(a) and 1(b)).
3.5. HVO 2299, Gene Encoding an Agmatinase-Like Protein,
Is Essential. The metabolic reconstruction described above
suggests a role of HVO 2299 as an agmatinase involved in
forming putrescine from agmatine (Figure 1(a)). However,
neither putrescine nor the downstream product spermidine
was detected in our polyamine analysis of Hfx. volcanii
(Figure 4). To gain further insight into the role of agmatinase,
the gene neighborhood of the HVO 2299 was explored
(Figure 2). Our analysis uncovered strong physical clustering
associations between the aIF5A and agmatinase encoding
genes, with 39% of the archaeal genomes present in the
STRING database (out of the 130 archaeal genomes) show-
ing this association (Figure 2). These clusters were almost
exclusively observed in Euryarchaeota and were present in
∼62% of the Euryarchaeota and in the unclassified archaea
halophilic archaeon DL31. Interestingly, the association
aIF5A/agmatinase was not found in the Crenarchaeota phy-
lum, where aIF5A was found associated with genes encoding
DNA topoisomerase IV subunit B, DNA topoisomerase VI
subunit A, and DHS (data not shown). Physical clustering
evidence strongly pointed to a role of HVO 2299 in aIF5a
modification.This agmatinase-like protein could be involved
in the formation of the intermediate putrescine (Figure 1(a)),
even if it has not been detected in our analyses or could
directly hydrolyze a modified aIF5a precursor to form the
final deoxyhypusine modification (Figure 1(d)).
To investigate if HVO 2299 is essential for Hfx. volcanii
cell viability, we attempted to delete the gene from its
chromosomal locus. Around 220 candidate colonies were
screened but no deletion mutant was obtained suggesting the
essentiality of this gene.Thedeletion of the gene failed even in
the presence of 1mM putrescine.We then proceeded to clone
the HVO 2299 into pPT002 plasmid, placing the gene under
the tryptophanase promoter [49, 83]. The plasmid was trans-
formed into the “pop-in strain.” In this background, it was
possible to delete the chromosomal copy of the HVO 2299
(Fig. S4 C-D), again strongly suggesting essentiality of the
gene. However, growth was still observed in the absence of
tryptophan, certainly caused by the known the leakiness of
the PTNA promoter in multicopy plasmids [49].
The fact that the HVO 2299 gene encoding an agmat-
inase-like protein is essential even in the presence of
putrescine, as well as the absence of any detected intracellular
putrescine, suggests that this enzyme is not involved in the
formation of putrescine from agmatine inHfx. volcanii. One,
however, cannot rule out the possibility that putrescine is
not imported in this organism and has to be produced
de novo and immediately used to modify aIF5a by DHS
(Figure 1(b)), reducing its accumulation to below detectable
limits. This is unlikely as all the genes encoding spermi-
dine/putrescine ABC transporter [PotA1 (HVO A293) and
PotA2 (HVO A293), PotB (HVO A300), PotC (HVO A297)
and PotD (HVO A299)] are found in the Hfx. volcanii
genome on the pHV4 plasmid in a physical cluster (data
not shown). If putrescine is transported in the cell, then
the essentiality of HVO 2299 would favor a model where
the agmatinase protein might be hydrolyzing the agmatine
moiety after its transfer to aIF5A (Figure 1(d)). Further efforts
are required to undercover the function of the agmatinase-
like protein in Hfx. volcanii.
3.6. Deoxyhypusine Synthase Activities in Euryarchaeota. 𝑁1-
Guanyl-1,7-diaminoheptane (GC7) is a very efficient inhibitor
of DHS in eukaryotes. This homolog of spermidine inhibits
the first step in the hypusination pathway by binding to
DHS [28, 29]. Cultures of Sulfolobus acidocaldarius DSM
639, Sulfolobus solfataricus DSM, Halobacterium halobium
DSM 670, and Haloferax mediterranei DSM were shown to
be sensitive to GC7 [33]. To determine the effect of GC7
on Hfx. volcanii culture, H26 was grown in the absence
or presence of 1mM GC7 at 42∘C on Hv min agar. As
shown in Figure 6(a), we did not observe any effect of
GC7 on the growth of H26 even if it should be transported
by the predicted spermidine/putrescine ABC transporter
present in Hfx. volcanii. The same results were observed in
liquid cultures, although the compound did affect growth
of Saccharomyces cerevisiae cultures as expected (data not
shown).
To determine whether the DHS of Hfx. volcanii transfers
the 4-aminobutylmoiety from spermidine to theHfx. volcanii
aIF5A lysine side chain, the protein was expressed from Hfx.
volcanii (LSP5021). The protein T7-His-DHS was purified as
a tetramer with an estimated molecular weight of around
148 kDa (Fig S6). The oligomerization state of the purified
DHS is in agreement with the crystal structure of the Human
and other characterizedDHS enzymes [84–86].The substrate
of the reaction, Hfx. volcanii aIF5A-C-term-His, was over-
expressed in E. coli and purified in two steps. The purified
Hfx. volcanii T7-His-DHS did not show any activity under
varying aIF5A concentration and substrate concentration
(spermidine, agmatine, cadaverine, and putrescine) (data not
shown). In an effort to determine if the lack of activity of
the DHS was due to the presence of the T7-His tag, the
protein was expressed without tag and the DHS activities
were tested in the Hfx. volcanii cell lysate. No DHS activity
was detected in the cell lysate (Fig. S7). The lack of activity
was not due to a defect of theHfx. volcanii aIF5A-C-term-His
substrate, since the S. cerevisiae DHS catalyzed the transfer
of 4-aminobutyl moiety from spermidine to theHfx. volcanii
aIF5a-C-term-His (Fig. S7, lane 11). DHS sequences from
Archaea that are sensitive to GC7 [34] (Fig. S8, group A) and
halophilic Archaea that harbor the polyamine cadaverine like
Hfx. volcanii (Fig. S8, group B) were aligned and the active
site and spermidine substrate binding residuesmapped. If the
active site K329 (Human, P49366) is strictly conserved from
Human to all archaeal DHS proteins, the spermidine binding
sites residues are not (Fig. S8). One of the spermidine binding
residues (H288) is strictly conserved in Eukarya and in the
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Figure 6: Hfx. volcanii is insensitive to GC7 and spermidine is the
substrate of T. kodakarensis DHS. (a) Effect of GC7 on the growth
of H26. Hfx. volcanii H26 (WT, parent) was diluted to OD
600
of 1
and then spot-plated (15𝜇L) on solid agar Hv min medium in serial
dilutions as indicated in absence or in presence of 1mM GC7. Each
experiment was performed with two biological replicates and three
technical replicates. (b) Detection of T. kodakarensis aIF5A (lanes 2,
3, 4, 6, 7, and 8) and S. cerevisiae eIF5A (lanes 1 and 5) modification
using [14C] spermidine or [3H] putrescine as substrates in presence
of T. kodakarensis DHS (lanes 3 and 7) or S. cerevisiae DHS (lanes
1, 2, and 5). The in vitro assay was resolved on a 16.5% tricine
polyacrylamide gel.The dried gels were exposed to autoradiography
films to visualize possible modifications. The assembly of each
reaction is depicted above. (i), Coomassie Blue staining; (ii), exposed
autoradiography film; (iii), overlay of the Coomassie Blue stained gel
and the exposed film; ∗ indicates the presence of the radioactivity;
molecular mass markers are indicated in kDa; T.k, Thermococcus
kodakarensis; S.c, Saccharomyces cerevisiae.
group A Archaea (sensitive to GC7) but this residue is not
conserved in the group B Archaea (that harbor cadaverine).
Those differences could explain why GC7 and spermidine do
not bind Hfx. volcanii DHS. This study opens the question of
DHS in halophile organisms.
As a further control, the in vitro DHS activity of another
member of the Euryarchaeota was explored. Recombinant
DHS from the thermophile T. kodakarensis and its sub-
strate aIF5A were purified and the activity was tested in
presence of radioactive spermidine or putrescine. Similar to
the eukaryotic enzyme (Figure 6(b), lane 1), the DHS of T.
kodakarensis transfers 4-aminobutyl from spermidine to T.
kodakarensis aIF5A in vitro (Figure 6(b), lane 3). No transfer
was observed in absence of the enzyme (Figure 6(b), lane 4) or
in presence of putrescine (Figure 6(b), lane 7). The modified
T. kodakarensis aIF5A was analyzed by mass spectrometry
demonstrating the presence of the deoxyhypusine on the
conserved lysine K42 (Fig. S9).
The absence of any effect of the GC7 on Hfx. volcanii
growth as well as the inability to observe transfer of 4-
aminobutyl suggests that spermidine is not the substrate of
the Hfx. volcanii DHS, corroborating the metabolic recon-
struction and the fact that no intracellular spermidine was
detected. We cannot rule out the possibility that GC7 was
not imported into the cells, despite the presence of the sper-
midine/putrescine ABC transporter genes and that the Hfx.
volcaniiDHSwas purified in an inactive form. Unfortunately,
our attempts to test the different models (Figures 1(b), 1(c),
and 1(d)) by testing the activity of the Hfx. volcanii DHS
protein in vitro remained unsuccessful. We were able to
purify an active aIF5A that could be deoxyhypusinylated
with the S. cerevisiae DHS using spermidine as aminobutyl
donor, but all attempts with Hfx. volcanii DHS failed using
spermidine, putrescine, or agmatine as donors. Nevertheless,
we could show for the first time the in vitro activity of the
T. kodakarensis DHS with the transfer of 4-aminobutyl from
spermidine to aIF5A, as in Eukaryotes.
4. Conclusion
We have demonstrated that Hfx. volcanii aIF5A is deoxy-
hypusinylated. The absence of spermidine in Hfx. volcanii
was confirmed, and the major polyamines in this halophile
were found to be agmatine and cadaverine. We propose that
deoxyhypusine synthesis in Hfx. volcanii differs from the
canonical eukaryotic pathway. Based on our observation that
(i) GC7, the spermidine analog that inhibits yeast DHS, does
not inhibitHfx. volcanii growth, (ii) the agmatinase-like gene
that clusters with the dhs gene is essential for the growth of
Hfx. volcanii even in the presence of putrescine, and (iii) there
is no activity of the Hfx. volcanii DHS with spermidine, we
favor themodel in Figure 1(d), whereDHS transfers agmatine
to the aIF5A lysine and the agmatinase enzyme is required to
produce deoxyhypusine.
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